M R Shalaby

5.5k total citations · 2 hit papers
45 papers, 4.7k citations indexed

About

M R Shalaby is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, M R Shalaby has authored 45 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 16 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in M R Shalaby's work include Immune Response and Inflammation (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Immunotherapy and Immune Responses (7 papers). M R Shalaby is often cited by papers focused on Immune Response and Inflammation (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Immunotherapy and Immune Responses (7 papers). M R Shalaby collaborates with scholars based in United States, France and Egypt. M R Shalaby's co-authors include Michael A. Palladino, Terje Espevik, L P Svedersky, B B Aggarwal, H. Michael Shepard, Emily Rinderknecht, Bryan S. Finkle, Ulrik B. Nielsen, James D. Marks and Anders Waage and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

M R Shalaby

43 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

2006 863 citations Dmitri B. Kirpotin, Daryl C. Drummond et al. Cancer Research profile →
Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.

1985 814 citations M R Shalaby, B B Aggarwal et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M R Shalaby United States	27	2.0k	1.7k	805	722	671	45	4.7k
Manuel L. Penichet United States	36	1.2k 0.6×	2.1k 1.2×	1.1k 1.4×	1.1k 1.5×	728 1.1×	107	4.9k
Patrice N. Marche France	42	2.2k 1.1×	1.9k 1.1×	470 0.6×	439 0.6×	255 0.4×	227	5.7k
Michael Papamichail Greece	40	3.2k 1.6×	1.8k 1.0×	1.8k 2.3×	730 1.0×	351 0.5×	155	6.5k
Geoffrey A. Pietersz Australia	37	2.3k 1.2×	2.5k 1.4×	716 0.9×	1.2k 1.7×	284 0.4×	113	4.6k
Hattie D. Gresham United States	34	3.3k 1.7×	2.7k 1.6×	384 0.5×	405 0.6×	313 0.5×	47	6.9k
Nirmal K. Banda United States	33	2.5k 1.3×	1.3k 0.7×	267 0.3×	485 0.7×	520 0.8×	87	4.7k
Frederik Dagnæs‐Hansen Denmark	38	1.7k 0.8×	2.3k 1.3×	695 0.9×	318 0.4×	328 0.5×	131	5.7k
Anita S. Chong United States	54	3.7k 1.8×	2.6k 1.5×	1.4k 1.7×	299 0.4×	548 0.8×	250	9.1k
Willem Den Otter Netherlands	31	1.3k 0.7×	822 0.5×	946 1.2×	395 0.5×	243 0.4×	193	3.6k
Marjolein van Egmond Netherlands	45	3.5k 1.8×	1.8k 1.0×	1.4k 1.8×	1.7k 2.3×	217 0.3×	126	6.8k

Countries citing papers authored by M R Shalaby

Since Specialization

Citations

This map shows the geographic impact of M R Shalaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M R Shalaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M R Shalaby more than expected).

Fields of papers citing papers by M R Shalaby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M R Shalaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M R Shalaby. The network helps show where M R Shalaby may publish in the future.

Co-authorship network of co-authors of M R Shalaby

This figure shows the co-authorship network connecting the top 25 collaborators of M R Shalaby. A scholar is included among the top collaborators of M R Shalaby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M R Shalaby. M R Shalaby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morsy, Heba, et al.. (2022). Significance of cancer testis-associated antigens (SPAG9 and FBXO39) in colon cancer. Indian Journal of Cancer. 59(3). 394–401.

Kirpotin, Dmitri B., Daryl C. Drummond, Yi Shao, et al.. (2006). Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models. Cancer Research. 66(13). 6732–6740. 863 indexed citations breakdown →

Powers, David B., Peter Amersdorfer, Marie‐Alix Poul, et al.. (2001). Expression of single-chain Fv-Fc fusions in Pichia pastoris. Journal of Immunological Methods. 251(1-2). 123–135. 105 indexed citations

Kotts, Claire E., Fu Su, Tom Dodd, et al.. (1996). ¹⁸⁶ Re-Labeled Antibodies to p185 ^HER2 as HER2-Targeted Radioimmunopharmaceutical Agents: Comparison of Physical and Biological Characteristics with ¹²⁵ I and ¹³¹ I-Labeled Counterparts. Cancer Biotherapy and Radiopharmaceuticals. 11(2). 133–144. 15 indexed citations

Carter, Paul, Maria Luı́sa Rodrigues, Gail D. Lewis Phillips, Irene S. Figari, & M R Shalaby. (1994). Towards an Immunotherapy for p185HER2 Overexpressing Tumors. Advances in experimental medicine and biology. 353. 83–94. 2 indexed citations

Shalaby, M R, H. Michael Shepard, Leonard G. Presta, et al.. (1992). Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene.. The Journal of Experimental Medicine. 175(1). 217–225. 138 indexed citations

Shalaby, M R, et al.. (1992). Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancement. Cytokine. 4(4). 269–280. 34 indexed citations

Shalaby, M R, Jostein Halgunset, L Aarden, et al.. (1991). Cytokine-associated tissue injury and lethality in mice: A comparative study. Clinical Immunology and Immunopathology. 61(1). 69–82. 22 indexed citations

Smeland, Erlend B., et al.. (1989). Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes.. The Journal of Experimental Medicine. 170(4). 1463–1468. 78 indexed citations

10.

Shalaby, M R, Anders Waage, & Terje Espevik. (1989). Cytokine regulation of interleukin 6 production by human endothelial cells. Cellular Immunology. 121(2). 372–382. 151 indexed citations

11.

Shalaby, M R, Anders Waage, L Aarden, & Terje Espevik. (1989). Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo. Clinical Immunology and Immunopathology. 53(3). 488–498. 247 indexed citations

12.

Shalaby, M R, et al.. (1988). Pharmacokinetics of Recombinant Murine Interferon-γ and Human Interferon-αA/D(Bgl) Administered in Concert and Their Influence on Natural Killer Cell Function in Mice. PubMed. 8(5). 597–608. 8 indexed citations

13.

Shalaby, M R, Terje Espevik, Glenn C. Rice, et al.. (1988). The involvement of human tumor necrosis factors- alpha and - beta in the mixed lymphocyte reaction.. The Journal of Immunology. 141(2). 499–503. 97 indexed citations

14.

Espevik, Terje, Irene S. Figari, M R Shalaby, et al.. (1987). Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.. The Journal of Experimental Medicine. 166(2). 571–576. 405 indexed citations

15.

Shalaby, M R, Michael A. Palladino, Sue E. Hirabayashi, et al.. (1987). Receptor Binding and Activation of Polymorphonuclear Neutrophils by Tumor Necrosis Factor-Alpha. Journal of Leukocyte Biology. 41(3). 196–204. 187 indexed citations

16.

Shalaby, M R, L P Svedersky, Patrick McKay, Bryan S. Finkle, & Michael A. Palladino. (1985). In Vivo Augmentation of Natural Killer Activity by Combined Treatment with Recombinant Gamma Interferon and Interleukin-2. Journal of Interferon Research. 5(4). 571–581. 23 indexed citations

17.

Shalaby, M R, et al.. (1985). In Vivo Antiviral Activity of Recombinant Murine Gamma Interferon. Journal of Interferon Research. 5(2). 339–345. 11 indexed citations

18.

Shalaby, M R, et al.. (1984). Activation of human polymorphonuclear neutrophils by lymphokines. Federation Proceedings. 43(7). 7 indexed citations

19.

Shalaby, M R, et al.. (1978). Isolation of Feline Syncytia-Forming Virus from Oropharyngeal Swab Samples and Buffy Coat Cells. American Journal of Veterinary Research. 39(4). 555–560. 8 indexed citations

20.

Auerbach, Robert & M R Shalaby. (1973). GRAFT-VS.-HOST REACTION IN TISSUE CULTURE. The Journal of Experimental Medicine. 138(6). 1506–1520. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact